Results 11 to 20 of about 190,349 (50)

Practical Guidance for the Expanded Implementation and Provision of Bispecific Antibodies for Diffuse Large B-Cell Lymphoma (DLBCL) Across Canada

open access: yesCurrent Oncology
(1) Background: Bispecific antibodies (BsAbs) for the treatment of relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) can be delivered in ambulatory healthcare settings; however, the safe and effective management of potential side effects ...
David MacDonald   +8 more
doaj   +1 more source

Evaluating Fatalism Among Breast Cancer Survivors in a Heterogeneous Hispanic Population: A Cross-Sectional Study

open access: yesCurrent Oncology
Hispanic breast cancer survivors reported worse quality of life, and fatalism is considered one of the mediators for this disparity. This study aimed to identify the factors associated with fatalism within a diverse Hispanic population.
Liara Lopez Torralba   +5 more
doaj   +1 more source

High Outcome-Reporting Bias in Randomized-Controlled Trials of Acupuncture for Cancer Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Epidemiological Study

open access: yesCurrent Oncology
Selective outcome-reporting bias refers to the selective reporting of a subset of study findings. This methodological limitation may occur in cancer-related acupuncture studies, where valid empirical studies on psychometric performance are still lacking.
Rachele Penati   +4 more
doaj   +1 more source

Understanding Chemotherapy-Induced Thrombocytopenia: Implications for Gastrointestinal Cancer Treatment

open access: yesCurrent Oncology
Chemotherapy-induced thrombocytopenia (CIT) is a common yet underrecognized complication of systemic chemotherapy, particularly in gastrointestinal (GI) cancers. Despite progress in targeted and immune-based therapies, platinum-based and fluoropyrimidine
Supriya Peshin   +5 more
doaj   +1 more source

A Narrative Review of the Roles of Nursing in Addressing Sexual Dysfunction in Oncology Patients

open access: yesCurrent Oncology
Sexual dysfunction affects an estimated 50–70% of cancer survivors but remains underrecognized and undertreated, impacting quality of life and emotional well-being.
Omar Alqaisi   +5 more
doaj   +1 more source

Impact of Adjuvant Cemiplimab in High-Risk Cutaneous Squamous Cell Carcinoma

open access: yesCurrent Oncology
Despite cutaneous squamous cell carcinoma (CSCC) being the second most common skin cancer worldwide, there were no approved systemic therapies for patients with unresectable and/or metastatic disease prior to the advent of anti-programmed cell death ...
Annette M. Lim   +2 more
doaj   +1 more source

Septic Shock in Hematological Malignancies: Role of Artificial Intelligence in Predicting Outcomes

open access: yesCurrent Oncology
Septic shock is a life-threatening complication of sepsis, particularly in patients with hematologic diseases who are highly susceptible to it due to profound immune dysregulation.
Maria Eugenia Alvaro   +6 more
doaj   +1 more source

How Musculoskeletal Tumor Management Changed During the COVID-19 Pandemic: Data from a Nationwide Questionnaire Survey of Hospitals Specializing in Musculoskeletal Tumors in Japan

open access: yesCurrent Oncology
Background: While changes in clinical practice during the COVID-19 pandemic in Japan have been widely studied, data specific to bone and soft tissue tumor care remain limited.
Takeshi Morii   +6 more
doaj   +1 more source

Implementing Person-Centered, Clinical, and Research Navigation in Rare Cancers: The Canadian Cholangiocarcinoma Collaborative (C3)

open access: yesCurrent Oncology
Person-centered navigation (PCN) in healthcare refers to a proactive collaboration among professionals, researchers, patients, and their families to guide individuals toward timely access to screening, treatment, follow-up, and psychosocial support.
Samar Attieh   +9 more
doaj   +1 more source

Evolving Treatment Paradigms in Metastatic Hormone-Sensitive Prostate Cancer: Expert Narrative Review

open access: yesCurrent Oncology
The treatment landscape of metastatic hormone-sensitive prostate cancer (mHSPC) has transformed significantly with the advent of triplet therapy involving androgen deprivation therapy (ADT), docetaxel, and androgen receptor signalling inhibitors (ARSIs).
Vineet Talwar   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy